Polybrene and interleukin-4: two opposing factors for retroviral transduction of bone-marrow-derived dendritic cells
- 12 July 2002
- journal article
- Published by Wiley in The Journal of Gene Medicine
- Vol. 4 (6) , 601-612
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Rapid Peptide Turnover and Inefficient Presentation of Exogenous Antigen Critically Limit the Activation of Self-Reactive CTL by Dendritic CellsThe Journal of Immunology, 2001
- Comparative Analysis of Genetically Modified Dendritic Cells and Tumor Cells as Therapeutic Cancer VaccinesJournal of Experimental Medicine, 2000
- Vaccination with Mage-3a1 Peptide–Pulsed Mature, Monocyte-Derived Dendritic Cells Expands Specific Cytotoxic T Cells and Induces Regression of Some Metastases in Advanced Stage IV MelanomaJournal of Experimental Medicine, 1999
- DENDRITIC CELLS AS REGULATORS OF IMMUNE REACTIVITY: IMPLICATIONS FOR TRANSPLANTATION1Transplantation, 1999
- Dendritic cells and the control of immunityNature, 1998
- Vaccination of melanoma patients with peptide- or tumorlysate-pulsed dendritic cellsNature Medicine, 1998
- Dendritic Cell Development: Multiple Pathways to Nature's AdjuvantsStem Cells, 1997
- Dendritic Cells Retrovirally Transduced with a Model Antigen Gene Are Therapeutically Effective against Established Pulmonary MetastasesJournal of Experimental Medicine, 1997
- Cell-surface receptors for retroviruses and implications for gene transfer.Proceedings of the National Academy of Sciences, 1996
- The Biochemistry and Cell Biology of Antigen Processing and PresentationAnnual Review of Immunology, 1993